BioSig Technologies Announces Pricing of Underwritten Public Offering of Common Stock

Strategic Insights -

BioSig Technologies, Inc. (BioSig or the Company), following its recent merger with Streamex Exchange Corporation (Streamex) (NASDAQ: BSGM), has announced the pricing of an underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025, subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses, are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital, and for general corporate purposes.

BioSig will use the funds to purchase gold bullion, which is in line with its investment policy. Additionally, the company will utilize the funds for working capital and general corporate purposes. BioSig has partnered with Clear Street and Needham & Company as joint book-running managers of the offering.

Key Takeaways:

  • BioSig Technologies has priced an underwritten public offering of 3,852,149 shares of common stock at $3.90 per share.
  • The offering is expected to close on or around August 15, 2025, subject to customary closing conditions.
  • The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses, are expected to be approximately $15,023,381.10.
  • BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital, and for general corporate purposes.
  • BioSig has partnered with Clear Street and Needham & Company as joint book-running managers of the offering.
  • The offering is being made in accordance with BioSig's shelf registration statement on Form S-3, which was declared effective by the Securities and Exchange Commission (SEC) on December 17, 2024.
  • BioSig will not, and has been advised by the joint book-running managers that they and their affiliates will not, sell any of the securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Statistics:

  • 3,852,149 shares of common stock will be sold through the underwritten public offering.
  • The public offering price of the common stock is $3.90 per share.
  • The gross proceeds from the offering are expected to be approximately $15,023,381.10.
  • The net proceeds from the offering will be used to purchase gold bullion, for working capital, and for general corporate purposes.
  • BioSig has a shelf registration statement on Form S-3, which was declared effective by the SEC on December 17, 2024.

Sources:

  • GlobeNewswire
  • BioSig Technologies, Inc.
  • Streamex Exchange Corporation (NASDAQ: BSGM)
  • Clear Street
  • Needham & Company
  • Securities and Exchange Commission (SEC)
  • National Association of Securities Dealers Automated Quotations (Nasdaq)